Get the Weekly Intelligence Brief — top committee picks every Sunday.
ACHC · NASDAQ · STOCK

Acadia Healthcare Company, Inc.

Healthcare Updated August 11, 2026
$31.09
52W $11.43 – $35.83
55/100
$2.90B
-2.5
0.64
AI Committee Verdict
Watch
55/100
Conviction: Contested · 50% agreement · 4 analysts
Contested

Is ACHC Bullish or Bearish?

Mixed. Innellis AI committee rates Acadia Healthcare Company, Inc. (ACHC) Watch with a composite score of 55/100 , based on 4 analysts with 50% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +4.69 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -15.31 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 27.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
  • Bollinger bandwidth of 27.5% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
55/100
Agreement
50%
Analysts
4
Conviction
Contested
Sector Rank
Top 79%
of 192 Healthcare peers
Technical Analyst neutral
51 / 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 27.5% signals elevated volatility
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
47.9
Neutral
MACD Histogram
-0.258
Bearish Momentum
Trend Direction
Uptrend
Weekly: Downtrend
Market Structure
Hh Hl
Bollinger %B
0.38
Inside Bands
Price vs Moving Averages
EMA 9
$31.31 Below
EMA 21
$31.22 Below
EMA 50
$29.69 Above
EMA 200
$25.38 Above

Fundamental Analysis

Valuation
100
Profitability
10
Financial Health
62
Cash Flow
15
Valuation
P/E Ratio -2.5×
P/B Ratio 1.43×
PEG Ratio 0.00
Dividend Yield 0.00%
52W High $35.83
52W Low $11.43
Quality & Growth
ROE -5658.3%
ROA -1995.1%
Gross Margin 3556.5%
Operating Margin 1006.0%
Revenue Growth YoY
Debt / Equity 1.30
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of -2.5 (inexpensive relative to a 15-40x range); Price-to-book of 1.4x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -56.6%; Return on assets of -20.0%; Net margin of -33.4%; Gross margin of 35.6%; Current ratio of 1.57 (healthy short-term liquidity); Debt-to-equity of 1.30; Free cash flow per share is negative (-0.21); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full ACHC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore ACHC Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime